Catalyst Private Wealth, LLC Karuna Therapeutics, Inc. Transaction History

Catalyst Private Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$161.01 - $317.85 $9.02 Million - $17.8 Million	56,018 Added 256.53%	77,855 $24.6 Million
Q4 2022 Jan 23, 2023	BUY	$191.53 - $236.82 $1.41 Million - $1.74 Million	7,361 Added 50.85%	21,837 $0
Q3 2022 Oct 12, 2022	SELL	$123.79 - $277.42 $1.3 Million - $2.91 Million	-10,500 Reduced 42.04%	14,476 $3.26 Million
Q4 2021 Jan 18, 2022	BUY	$110.64 - $159.4 $771,160 - $1.11 Million	6,970 Added 38.71%	24,976 $3.27 Million
Q3 2021 Oct 20, 2021	BUY	$101.2 - $125.87 $506,000 - $629,350	5,000 Added 38.44%	18,006 $2.2 Million
Q4 2020 Mar 05, 2021	BUY	$75.23 - $109.23 $601,840 - $873,840	8,000 Added 159.81%	13,006 $1.32 Million
Q3 2020 Nov 19, 2020	BUY	$71.31 - $109.74 $356,977 - $549,358	5,006 New	5,006 $387,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Catalyst Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Private Wealth, LLC with notifications on news.